Create Free Account

By creating account you will get access to hot stocks & personalised emails

Live Verdure Ltd

Healthcare AU LV1

0.73AUD
0.03(4.29%)

Last update at 2024-11-13T05:10:00Z

Day Range

0.680.73
LowHigh

52 Week Range

0.300.90
LowHigh

Fundamentals

  • Previous Close 0.70
  • Market Cap102.12M
  • Volume489149
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-12.12620M
  • Revenue TTM1.94M
  • Revenue Per Share TTM0.02
  • Gross Profit TTM 1.42M
  • Diluted EPS TTM-0.11

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -2.83422M -3.96406M -3.45740M -1.31849M -0.44626M
Minority interest - - - - -
Net income -2.83422M -3.96406M -3.45740M -1.31849M -0.44626M
Selling general administrative 4.24M 1.00M 2.25M 1.70M 0.51M
Selling and marketing expenses - 3.20M 1.22M - -
Gross profit 1.57M 1.44M 0.28M 0.56M 0.09M
Reconciled depreciation 0.04M 0.00562M 0.00702M - -
Ebit -2.71097M -3.10451M -3.22698M -1.20768M -0.44297M
Ebitda -2.66763M -3.09889M -3.21996M - -
Depreciation and amortization - 0.00562M 0.00702M - -
Non operating income net other - - - - -
Operating income -2.70926M -3.10451M -3.22698M -1.20605M -0.44626M
Other operating expenses -0.15208M 5.14M 3.96M -0.05076M 0.00292M
Interest expense 0.12M 0.86M 0.23M 0.00000M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.12M 0.86M 0.00125M 0.04M -
Net interest income -0.12325M -0.85853M -0.22916M - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 1.01M 0.36M - -
Total revenue 2.41M 1.89M 0.61M 0.40M 0.23M
Total operating expenses - 4.70M 3.64M - -
Cost of revenue 0.84M 0.45M 0.33M -0.16112M 0.15M
Total other income expense net 0.19M 0.15M 0.13M - -
Discontinued operations - - - - -
Net income from continuing ops -2.83422M -3.96406M -3.45740M - -
Net income applicable to common shares -2.83422M -3.96406M -3.45740M -1.31849M -0.44626M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 4.59M 2.49M 1.29M 4.17M 5.59M
Intangible assets - 1.18M - - -
Earning assets - - - - -
Other current assets 0.01M 0.00418M 0.00110M 0.00110M 0.10M
Total liab 1.95M 1.57M 0.92M 0.46M 0.36M
Total stockholder equity 2.64M 0.92M 0.36M 3.71M 5.23M
Deferred long term liab - - - - -
Other current liab 0.02M 0.70M 0.28M 0.13M 0.00652M
Common stock 12.71M 9.71M 7.05M 6.98M 7.00M
Capital stock - 9.71M 7.05M 6.98M 7.00M
Retained earnings -22.42950M -12.23476M -9.40053M -5.43648M -3.87740M
Other liab - 0.34M - 0.00590M 0.00115M
Good will - - - - -
Other assets 0.00000M - - - -
Cash 1.10M 0.17M 0.53M 3.66M 5.16M
Cash and equivalents - - - - -
Total current liabilities 1.95M 1.23M 0.92M 0.45M 0.35M
Current deferred revenue 1.31M - - - -
Net debt -1.08074M - -0.53307M -3.65806M -5.11557M
Short term debt 0.02M 0.00000M 0.00000M 0.00000M 0.03M
Short long term debt - - - - -
Short long term debt total 0.02M - - - 0.04M
Other stockholder equity 12.35M 3.44M 2.71M 2.16M -
Property plant equipment - 0.05M 0.02M 0.03M 0.04M
Total current assets 1.63M 1.27M 1.26M 4.14M 5.55M
Long term investments - - - - -
Net tangible assets - -0.25226M 0.36M 3.71M -0.28389M
Short term investments - 0.00418M 0.00110M 0.00110M -
Net receivables 0.08M 0.13M 0.10M 0.07M 0.06M
Long term debt - - - - -
Inventory 0.44M 0.92M 0.59M 0.36M 0.24M
Accounts payable 0.60M 0.44M 0.64M 0.32M 0.31M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - 2.71M 2.16M 2.11M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1.13M - - - -
Deferred long term asset charges - - - - -
Non current assets total 2.96M 1.23M 0.02M 0.03M 0.04M
Capital lease obligations - 0.04M - - 0.04M
Long term debt total - 0.00000M 0.00000M 0.00000M 0.01M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.74988M - - - -
Change to liabilities 0.27M 0.00000M 0.14M 0.08M 0.00000M
Total cashflows from investing activities -0.74988M -0.74988M -0.74988M -0.00412M -0.11018M
Net borrowings - - - 0.57M -0.35000M
Total cash from financing activities 3.12M 0.07M 4.99M 1.34M 0.55M
Change to operating activities -0.59131M 0.48M 0.03M -0.07223M -0.07223M
Net income -2.83422M -3.96406M -3.45740M -1.31849M -0.44626M
Change in cash -0.36451M -3.12498M 3.51M -0.02267M 0.08M
Begin period cash flow 0.53M 3.66M 0.14M - -
End period cash flow 0.17M 0.53M 3.66M 0.14M -
Total cash from operating activities -2.73563M -3.19278M -1.47084M -1.35483M -0.36050M
Issuance of capital stock 3.38M 0.08M 5.50M - -
Depreciation 0.07M 0.00562M 0.00700M 0.08M 0.02M
Other cashflows from investing activities -0.74988M 0.00000M - 0.00000M -0.00875M
Dividends paid - - - - -
Change to inventory -0.32617M -0.23397M 0.06M -0.22470M -0.22470M
Change to account receivables -0.03257M -0.02422M 0.03M -0.01031M -0.01031M
Sale purchase of stock 3.38M -0.01336M -0.50891M 0.78M 0.95M
Other cashflows from financing activities -0.26400M -0.01336M -0.51438M -0.01165M -0.04715M
Change to netincome 0.70M 0.77M 1.72M 0.11M 0.07M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00412M 0.10M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -2.73563M -3.19278M -1.47084M -1.35483M -0.36050M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow -2.73563M -3.19278M -1.47084M - -

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
LV1
Live Verdure Ltd		 0.03 4.29% 0.73 - - 52.75 39.01 42.66 -5.083
AFP
AFT Pharmaceuticals Ltd		 -0.02 0.78% 2.55 17.71 19.08 1.35 3.31 1.56 10.94
VLS
Vita Life Sciences Ltd		 - -% 2.09 12.06 - 1.46 2.42 1.15 6.64
PER
Percheron Therapeutics Limited		 -0.003 3.53% 0.08 - - 27.59 8.75 347.00 -4.4641
VIT
Vitura Health Limited		 -0.003 3.06% 0.10 9.50 - 0.44 1.46 0.45 7.74

Reports Covered

Stock Research & News

View All

Profile

Live Verdure Ltd, a health, wellness, and skincare company, engages in the development of various naturally based products in Australia. The company offers hemp-based food, beauty and nutraceutical products, and skincare products. It sells its products under the 13 Seeds, 8 Seeds, and Edible Beauty Australia brand names through online sale. The company was formerly known as 13 Seeds Ltd. and changed its name to Live Verdure Limited in October 2020. Live Verdure Ltd was incorporated in 2016 and is based in Sydney, Australia.

Live Verdure Ltd

137-139 Bathurst Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA CFO & Company Sec. NA
Mr. Jonathan Do Chief Technical Officer NA
Mr. Asaf Katz Head of Online Growth NA
Mr. Gernot Kurt Abl Interim CEO & Executive Chairman NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA CFO & Company Secretary NA
Mr. Gernot Kurt Abl Interim CEO & Executive Chairman NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA CFO & Company Secretary NA
Mr. Gernot Kurt Abl Interim CEO & Executive Chairman NA
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA CFO & Company Secretary NA
Mr. Gernot Kurt Abl Interim CEO & Executive Chairman NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.